In the Kaplan–Meier Plotter database, MIDN expression was also negatively associated with the OS and relapse-free survival (RFS) in esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC, Figure 3E–H). Here, MIDN is linked to esophageal adenocarcinoma.